JP2023502053A5 - - Google Patents

Info

Publication number
JP2023502053A5
JP2023502053A5 JP2022528008A JP2022528008A JP2023502053A5 JP 2023502053 A5 JP2023502053 A5 JP 2023502053A5 JP 2022528008 A JP2022528008 A JP 2022528008A JP 2022528008 A JP2022528008 A JP 2022528008A JP 2023502053 A5 JP2023502053 A5 JP 2023502053A5
Authority
JP
Japan
Prior art keywords
drug
copies
log
less
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502053A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/082102 external-priority patent/WO2021094563A1/en
Publication of JP2023502053A publication Critical patent/JP2023502053A/ja
Publication of JP2023502053A5 publication Critical patent/JP2023502053A5/ja
Pending legal-status Critical Current

Links

JP2022528008A 2019-11-15 2020-11-13 デング病の治療及び予防 Pending JP2023502053A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP19209593.3 2019-11-15
EP19209593 2019-11-15
EP19213851.9 2019-12-05
EP19213851 2019-12-05
EP20171172 2020-04-23
EP20171172.8 2020-04-23
PCT/EP2020/082102 WO2021094563A1 (en) 2019-11-15 2020-11-13 Treatment and prevention of dengue disease

Publications (2)

Publication Number Publication Date
JP2023502053A JP2023502053A (ja) 2023-01-20
JP2023502053A5 true JP2023502053A5 (cg-RX-API-DMAC7.html) 2023-11-21

Family

ID=73288639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528008A Pending JP2023502053A (ja) 2019-11-15 2020-11-13 デング病の治療及び予防

Country Status (14)

Country Link
US (1) US12702657B2 (cg-RX-API-DMAC7.html)
EP (1) EP4058019A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023502053A (cg-RX-API-DMAC7.html)
KR (1) KR20220101679A (cg-RX-API-DMAC7.html)
CN (1) CN114980884A (cg-RX-API-DMAC7.html)
AU (1) AU2020382911A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022009199A2 (cg-RX-API-DMAC7.html)
CA (1) CA3161338A1 (cg-RX-API-DMAC7.html)
IL (1) IL292970A (cg-RX-API-DMAC7.html)
MX (1) MX2022005879A (cg-RX-API-DMAC7.html)
PH (1) PH12022551160A1 (cg-RX-API-DMAC7.html)
TW (1) TW202132269A (cg-RX-API-DMAC7.html)
UA (1) UA129409C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021094563A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119173261A (zh) * 2022-05-12 2024-12-20 杨森制药公司 登革热病毒感染的治疗和/或预防
WO2025248536A1 (en) * 2024-05-29 2025-12-04 Zydus Lifesciences Limited Novel oxime derivatives to treat viral infections
WO2025253267A1 (en) 2024-06-06 2025-12-11 Janssen Pharmaceuticals, Inc. Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1200899A (en) 1997-10-27 1999-05-17 Eli Lilly And Company Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
EP1261610A2 (en) 2000-02-17 2002-12-04 Bristol-Myers Squibb Pharma Company Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
GB0110832D0 (en) 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
EP1519735A4 (en) 2001-12-12 2006-01-11 Conforma Therapeutic Corp ASSAYS AND DEVICES FOR DETERMINING AND MODULATING HSP90 BINDING ACTIVITY
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
EP1749007A2 (en) 2004-03-30 2007-02-07 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
NZ555142A (en) 2004-12-23 2010-03-26 Novartis Ag Compounds for flaviviridae treatment
CN101103026A (zh) 2005-01-14 2008-01-09 健亚生物科技公司 用于治疗病毒感染的吲哚衍生物
AU2006221080A1 (en) 2005-02-09 2006-09-14 Migenix Inc. Compositions and methods for treating or preventing flaviviridae infections
DE102005028845A1 (de) 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
WO2007017093A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 2-benzyloxy-benzoic acid amide derivatives
CN101253152A (zh) 2005-09-02 2008-08-27 安斯泰来制药株式会社 作为rock抑制剂的酰胺衍生物
FR2928645A1 (fr) 2008-03-14 2009-09-18 Sanofi Aventis Sa Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
CN102056483A (zh) 2008-06-03 2011-05-11 西佳技术公司 用于治疗或预防登革病毒感染的小分子抑制剂
MX2011001872A (es) 2008-08-18 2011-05-23 Univ Yale Moduladores de mif.
EP2331499B1 (en) 2008-08-19 2016-09-21 Janssen Pharmaceutica NV Cold menthol receptor antagonists
TWI453207B (zh) 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶,其組合物及使用其之治療方法
WO2010091413A1 (en) 2009-02-09 2010-08-12 Enanta Pharmaceuticals, Inc. Linked dibenzimidazole derivatives
GB0910003D0 (en) 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
CA2771124C (en) 2009-09-09 2019-01-15 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
EA201290575A1 (ru) 2010-01-15 2013-01-30 Джилид Сайэнс, Инк. Ингибиторы вирусов flaviviridae
WO2011120025A1 (en) 2010-03-26 2011-09-29 Glaxo Group Limited Indazolyl-pyrimidines as kinase inhibitors
JP5716205B2 (ja) 2011-03-29 2015-05-13 学校法人日本大学 グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
MX368158B (es) 2013-10-23 2019-09-20 Janssen Sciences Ireland Uc Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
JP6505727B2 (ja) 2014-01-31 2019-04-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ヘテロ環式p2’基を有する第xia因子阻害剤としてのマクロ環
KR102382905B1 (ko) 2014-06-04 2022-04-04 프레드 헛친슨 켄서 리서치 센터 노치 1 및/또는 노치 2 작용제를 사용한 줄기 세포의 확장 및 생착
KR102391259B1 (ko) 2014-06-04 2022-04-26 암젠 인크 포유류 세포 배양물을 회수하는 방법
BR112017006708A2 (pt) 2014-10-01 2017-12-26 Janssen Pharmaceuticals Inc indóis mono- ou dissubstituídos como inibidores da replicação viral de dengue
US9944598B2 (en) 2014-10-01 2018-04-17 Janssen Pharmaceuticals, Inc. Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
NO2721243T3 (cg-RX-API-DMAC7.html) 2014-10-01 2018-10-20
ES2896198T3 (es) 2014-10-10 2022-02-24 Univ Rutgers Cebadores y sondas de reacción en cadena de polimerasa para Mycobacterium tuberculosis
PH12017501272B1 (en) 2015-01-16 2023-01-11 Janssen Pharmaceuticals Inc Indole derivatives as dengue viral replication inhibitors
AR103680A1 (es) 2015-02-23 2017-05-24 Lilly Co Eli Inhibidores selectivos de bace1
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JP6636133B2 (ja) 2015-07-22 2020-01-29 オメイコス セラピューティクス ゲーエムベーハー 心疾患の治療に対するcyp−エイコサノイドの代謝的にロバストな類縁体
JOP20160198B1 (ar) 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CA3002214C (en) 2015-11-03 2022-01-04 Zoetis Services Llc Sol-gel polymer composites and uses thereof
EP3433274A1 (en) 2016-03-25 2019-01-30 Visterra, Inc. Formulation of antibody molecules to dengue virus
WO2017167953A1 (en) 2016-03-31 2017-10-05 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
HRP20210847T1 (hr) 2016-03-31 2021-07-23 Janssen Pharmaceuticals, Inc. Supstituirani derivati indola kao inhibitori replikacije denga virusa
UY37174A (es) 2016-03-31 2017-10-31 Takeda Pharmaceuticals Co Un compuesto heterocíclico que tiene una acción inhibidora de monoacilglicerol lipasa
AU2017240801A1 (en) 2016-04-01 2018-10-25 Amgen Inc. Chimeric receptors to FLT3 and methods of use thereof
KR102427334B1 (ko) 2016-04-01 2022-08-03 카이트 파마 인코포레이티드 키메라 항원 및 t 세포 수용체 및 사용 방법
US10576085B2 (en) 2016-04-01 2020-03-03 Signal Pharmaceuticals, Llc Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
EA201892200A1 (ru) 2016-04-01 2019-03-29 Янссен Фармасьютикалз, Инк. Замещенные производные соединений индола в качестве ингибиторов репликации вирусов денге
SG10201912519VA (en) 2016-04-01 2020-02-27 Kite Pharma Inc Chimeric receptors and methods of use thereof
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
MX2018012016A (es) 2016-04-01 2019-01-24 Basf Se Compuestos biciclicos.
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CR20190531A (es) 2017-05-22 2020-03-05 Janssen Pharmaceuticals Inc Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
CA3060583C (en) 2017-05-22 2024-06-04 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors

Similar Documents

Publication Publication Date Title
DK168514B1 (da) Synergistisk produkt indeholdende en kombination af amantadin og selegilin, fremgangsmåde til fremstilling af produktet og anvendelse af amantadin og selegilin til fremstilling af produktet
SK112001A3 (en) Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug
JP2023540149A (ja) 抗ウイルス化合物の製剤
JP2022554276A5 (cg-RX-API-DMAC7.html)
JP2023546565A5 (cg-RX-API-DMAC7.html)
JPWO2023054732A5 (cg-RX-API-DMAC7.html)
JP2022531251A5 (cg-RX-API-DMAC7.html)
CN111867582A (zh) 衣壳组装调节剂给药方案
JP2025508656A5 (cg-RX-API-DMAC7.html)
JP2024518558A5 (cg-RX-API-DMAC7.html)
CN1191061C (zh) 药用组合物
BG60400B2 (bg) Синергитични фармацевтични препарати, тяхното получаване и употребата им
JP2023531930A5 (cg-RX-API-DMAC7.html)
JP2017508737A5 (cg-RX-API-DMAC7.html)
JP2023502053A (ja) デング病の治療及び予防
JP2019531286A5 (cg-RX-API-DMAC7.html)
JP2023011549A5 (cg-RX-API-DMAC7.html)
JP2021091608A5 (cg-RX-API-DMAC7.html)
CN113557016A (zh) 衣壳组装调节剂固体配制品
WO2016053121A1 (en) Antiviral pharmaceutical formulation for the treatment of dengue, influenza and hiv/aids
JP2025517683A5 (cg-RX-API-DMAC7.html)
JP2025521501A5 (cg-RX-API-DMAC7.html)
JP2015520759A5 (cg-RX-API-DMAC7.html)
JP3885135B2 (ja) C型又は非b非c型肝炎ウイルスによる肝機能異常の改善剤
TW536400B (en) Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection